🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with my dad had a heart attack and now i am terrified - will glp-1 help?? Page 2

Has anyone dealt with my dad had a heart attack and now i am terrified - will glp-1 help??

chris_chi24 Sat, Jan 10, 2026 at 1:08 PM 18 replies 1,212 viewsPage 2 of 4
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Jan 10, 2026 at 5:01 PM#6
Dr.ObesityLA said:
Lp(a) and cardiovascular risk: a nuance that matters.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

Last edited: Jan 10, 2026 at 10:01 PM
36 14denise_HTX, raj_cambridge, ingrid_STO and 33 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jan 10, 2026 at 6:32 PM#7
chris_chi24 said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off amlodipine entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

37 15JessicaH_TX, KevinCompounds, TirzTom and 34 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Jan 10, 2026 at 8:03 PM#8
NurseKim_ATL said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 6.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 1.5 mg/L (moderate risk)
Month 12 hsCRP: 0.4 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 13% to 4%. My cardiologist is genuinely impressed.

38 16mike_mod, SarahChen_PharmD, sarah.morrison and 35 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
SkepticalSean
Member
98
345
Jan 2025
Maine
Jan 10, 2026 at 9:34 PM#9

Following on from ZaraB_AL — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

39 17tammy_FL, Dr.LipidDallas, alex_tucson and 36 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Jan 11, 2026 at 4:50 AM#10
pete_nash said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 6.0 mg/L (high cardiovascular risk) Month 6 hsCRP:…

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

Last edited: Jan 11, 2026 at 7:50 AM
3 3SleepFixSam, PurityPaulOR, MaxMetOK
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register